Immunoglobulin kappa variable 2-19 (pseudogene) (IGKV2-19)

The immunoglobulin kappa variable 2-19 (IGKV2-19) gene encodes a variable region segment for the kappa light chain of immunoglobulins, but in humans, it is classified as a pseudogene and does not produce a functional protein. Variable region genes like these contribute to antibody diversity, but pseudogenes such as IGKV2-19 are generally not transcribed or translated into protein products, and thus are not considered direct therapeutic or diagnostic targets in clinical practice. According to GeneCards, IGKV2-19 is specifically annotated as a pseudogene in humans. Pseudogenes do not produce functional proteins and are not typical receptors, enzymes, or drug targets. No evidence links IGKV2-19 with being a therapeutic target, disease biomarker, or drug-interacting protein, nor are there safety concerns or mechanism-of-action data available for it. Although immunoglobulin variable genes in general are essential for immune response and antibody diversity, pseudogenes like IGKV2-19 lack biological function in this context. There are no known drugs or mechanisms of action related to this locus.

Other names

A28IGKV219IGKV2-19